Ajooni Biotech IPO is a Fixed Price IPO listing on NSE EMERGE exchange, with an ipo size of ₹ 6.59 Cr. The company is based in Mohali and caters to Agro sector. Navigant Corporate Advisors is the merchant banker of Ajooni Biotech IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 27th October 2017.
Ajooni Biotech IPO open date is 20th December 2017 and close date is 22nd December 2017. IPO Allotment Date is 30th November -0001 and Listing date is 2nd January 2018.Ajooni Biotech IPO size is ₹ 6.59 Cr. with IPO price of ₹ 30.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Navigant Corporate Advisors Limited is the book-running lead manager of the Ajooni Biotech IPO. Cameo Corporate Services Limited is the Registrar and Market Maker is Share India Securities Limited for Ajooni Biotech IPO.
Ajooni Biotech IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Ajooni Biotech IPO, based in Mohali, operates in the Agro sector with a focus on manufacturing of cattle feed. The company is launching its SME IPO on the NSE EMERGE exchange, using the Fixed Price Issue method. Ajooni Biotech IPO size is ₹ 6.59 Cr. with fresh issue size of ₹ 6.59 Cr. and Offer for sale being ₹ Nil
The IPO allotment date for Ajooni Biotech IPO is expected to be 30th November -0001, after the finalization of basis of allotment. Investors can check Ajooni Biotech IPO allotment status on the registrars website, Cameo Corporate Services Limited . Ajooni Biotech IPO refund dates are 30th November -0001.
Ajooni Biotech IPO is expected to be listed on 2nd January 2018.
The upper price band for the Ajooni Biotech IPO is set at ₹ 30.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Ajooni Biotech IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Ajooni Biotech IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 22nd December 2017. After submission, funds are blocked until the basis of allotment of Ajooni Biotech IPO is finalised.
The merchant banker for Ajooni Biotech IPO is Navigant Corporate Advisors Limited . Navigant Corporate Advisors Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Ajooni Biotech IPO RHP for further details.
The registrar for Ajooni Biotech IPO is Cameo Corporate Services Limited . Investors can go to Cameo Corporate Services Limited registrar website for IPO allotment status, refund processing, and other queries related to Ajooni Biotech IPO through their official website or helpline.
Ajooni Biotech IPO was subscribed [●] times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
Ajooni Biotech IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Ajooni Biotech Financial Review Page
Merchant Banker(s) of Ajooni Biotech IPO: Navigant Corporate Advisors Limited
Ajooni Biotech IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Ajooni Biotech IPO listed at a listing price of 36.00 against the offer price of 30.00.
The current market price of Ajooni Biotech is 6.03.
Why Us?